Cardiovascular · 2023

FDA-cleared AI devices for cardiovascular 2023

2023 has 21 cardiovascular AI devices, 50% more than 2022 (14). That is 13.6% of the 154 cardiovascular devices on the FDA list, and 9.3% of all AI-device decisions dated 2023. The most active were Medtronic, Inc. (3), Volta Medical (2), Alio, Inc. (1). The newest is LINQ II Insertable Cardiac Monitor from Medtronic, Inc., decided on December 6, 2023.

212023 devices
18Companies
9.3%Of all 2023 AI devices
13.6%Of all cardiovascular

By month

Jan: 1Feb: 1Mar: 1Apr: 2May: 2Jun: 0Jul: 3Aug: 2Sep: 6Oct: 2Nov: 0Dec: 1
JanFebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2023: Jan 1, Feb 1, Mar 1, Apr 2, May 2, Jun 0, Jul 3, Aug 2, Sep 6, Oct 2, Nov 0, Dec 1

All 21 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2023?

21 AI-enabled cardiovascular devices have a final decision dated 2023, from 18 companies.

How does 2023 compare with 2022 for AI cardiovascular devices?

2023 has 21 cardiovascular AI devices, 50% more than 2022 (14).

Which companies cleared the most AI cardiovascular devices in 2023?

Medtronic, Inc. (3), Volta Medical (2), Alio, Inc. (1).

What was the most recent AI cardiovascular device in 2023?

LINQ II Insertable Cardiac Monitor from Medtronic, Inc. (K233562), decided on December 6, 2023. Product code MXD.

Which product codes were most common for AI cardiovascular devices in 2023?

DQK (Computer, Diagnostic, Programmable): 4; MXD (Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)): 3; QNL (Medium-Term Adjunctive Predictive Cardiovascular Indicator): 2.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2023,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2023 (FDA list through 2026-06-29).